[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sunshine Biopharma (SBFM)

Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,924
  • Shares Outstanding, K 3,877
  • Annual Sales, $ 36,310 K
  • Annual Income, $ -5,980 K
  • EBIT $ -7 M
  • EBITDA $ -5 M
  • 60-Month Beta 1.16
  • Price/Sales 0.13
  • Price/Cash Flow N/A
  • Price/Book 0.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-1.90
  • Growth Rate Est. (year over year) +52,678.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0100 +25.74%
on 08/26/26
1.5700 -19.11%
on 07/28/26
-0.2600 (-16.99%)
since 07/27/26
3-Month
1.0100 +25.74%
on 08/26/26
3.7720 -66.33%
on 05/28/26
-2.9740 (-70.08%)
since 05/27/26
52-Week
1.0100 +25.74%
on 08/26/26
24.3000 -94.77%
on 10/16/25
-13.5300 (-91.42%)
since 08/27/25

Most Recent Stories

More News
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:BNTX),(NYSE:AZN),(NASDAQ:MRNA),(NYSE:BMY) EQNX::TICKER_END

SBFM : 1.2700 (+2.42%)
AZN : 164.52 (-1.05%)
MRNA : 142.77 (-4.60%)
BNTX : 111.40 (-1.03%)
BMY : 66.95 (-0.92%)
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where cancer treatment is headed, mRNA cancer vaccines are hard to ignore—especially in lung cancer. The...

SBFM : 1.2700 (+2.42%)
AZN : 164.52 (-1.05%)
MRNA : 142.77 (-4.60%)
BMY : 66.95 (-0.92%)
BNTX : 111.40 (-1.03%)
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

FORT LAUDERDALE, FL / ACCESS Newswire / March 24, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

FORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas...

SBFM : 1.2700 (+2.42%)
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of...

SBFM : 1.2700 (+2.42%)

Business Summary

Sunshine Biopharma Inc. is a pharmaceutical company. It focused on the research, development and commercialization of oncology and antiviral drugs. Sunshine Biopharma Inc. is based in MONTREAL.

See More

Key Turning Points

3rd Resistance Point 1.4400
2nd Resistance Point 1.3700
1st Resistance Point 1.3200
Last Price 1.2700
1st Support Level 1.2000
2nd Support Level 1.1300
3rd Support Level 1.0800

See More

52-Week High 24.3000
Fibonacci 61.8% 15.4032
Fibonacci 50% 12.6550
Fibonacci 38.2% 9.9068
Last Price 1.2700
52-Week Low 1.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.